Bendanillo, Chrizilda T.

HRN: 12-84-97  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2026
CO-AMOXICLAV 625MG (TAB)
06/18/2026
06/25/2026
PO
500mg
BID
PROM; S/P NSVD
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: